Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-2010 + Sacituzumab Tirumotecan in Advanced Solid Tumors
NCT07785609Phase 2Recruiting
- Sponsor
- Merck & Co.
- Start
- Oct 2026
- Primary completion
- Sep 2031
- Countries
- 3
01
Overview
A Phase 2 trial of MK-2010 in solid tumor (advanced stage), sponsored by Merck & Co.. Started Oct 2026; status: recruiting.
02
Drugs
MK-2010
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT07785609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07785609.